Literature DB >> 18703580

Expression of small-conductance calcium-activated potassium channels (SK3) in skeletal muscle: regulation by muscle activity.

Morgana Favero1, De-Jian Jiang, Christian Chiamulera, Alberto Cangiano, Guido Francesco Fumagalli.   

Abstract

The type 3 small conductance calcium-activated potassium channel (SK3) is expressed in embryonic and adult denervated skeletal muscles where it contributes to hyperexcitability. This study aimed at determining the role of muscle activity in regulating SK3 channels. Soleus muscles of adult rats were denervated by cutting the sciatic nerve. In reinnervation studies, the soleus nerve was crushed: in one group, muscles were reinnervated with electrically silent axons, by chronic sciatic nerve perfusion with tetrodotoxin. Several groups of denervated muscles were subjected to chronic direct electrical stimulation, using either fast (100 Hz) or slower patterns (20 or 30 Hz). The SK3 mRNA and protein levels in soleus muscle were determined by reverse transcriptional-PCR, Western blot and immunofluorescence. Both denervated and reinnervated-paralysed soleus muscles displayed similar up-regulation of SK3 mRNA and protein. Reinnervation with electrically active axons instead inhibited SK3 up-regulation. Chronic muscle direct stimulation in vivo, irrespective of the pattern used, reversed the denervation-induced up-regulation of SK3 expression or prevented it when initiated at the time of denervation. Chronic electrical stimulation of denervated muscles also completely prevented the development of the after-hyperpolarization (AHP) following the action potential, normally induced in the muscle fibres by denervation. We conclude that action potential activity evoked by motor neurones in muscle fibres is both necessary and sufficient to account for the physiological down-regulation of SK3 channels in the non-junctional membrane of skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703580      PMCID: PMC2614046          DOI: 10.1113/jphysiol.2008.156588

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  47 in total

1.  Presynaptic localization of the small conductance calcium-activated potassium channel SK3 at the neuromuscular junction.

Authors:  R Roncarati; M Di Chio; A Sava; G C Terstappen; G Fumagalli
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy.

Authors:  T Kimura; M P Takahashi; Y Okuda; M Kaido; H Fujimura; T Yanagihara; S Sakoda
Journal:  Neurosci Lett       Date:  2000-12-08       Impact factor: 3.046

3.  A soluble factor (less than 4000 Da) from chick spinal cord blocks slow hyperpolarizing afterpotentials in cultured rat muscle cells.

Authors:  B A Suarez-Isla; J W Cosgrove; J M Thompson; S I Rapoport
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

4.  Firing patterns of motor units in normal rats.

Authors:  R Hennig; T Lømo
Journal:  Nature       Date:  1985 Mar 14-20       Impact factor: 49.962

5.  The all-or-none role of innervation in expression of apamin receptor and of apamin-sensitive Ca2+-activated K+ channel in mammalian skeletal muscle.

Authors:  H Schmid-Antomarchi; J F Renaud; G Romey; M Hugues; A Schmid; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  Expression of apamin receptor in muscles of patients with myotonic muscular dystrophy.

Authors:  J F Renaud; C Desnuelle; H Schmid-Antomarchi; M Hugues; G Serratrice; M Lazdunski
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

7.  Role of apamin-sensitive k(ca) channels for reticulospinal synaptic transmission to motoneuron and for the afterhyperpolarization.

Authors:  Lorenzo Cangiano; Peter Wallén; Sten Grillner
Journal:  J Neurophysiol       Date:  2002-07       Impact factor: 2.714

8.  Increase of apamin receptors in skeletal muscle induced by colchicine: possible role in myotonia.

Authors:  M I Behrens; C Vergara
Journal:  Am J Physiol       Date:  1992-10

9.  Single apamin-blocked Ca-activated K+ channels of small conductance in cultured rat skeletal muscle.

Authors:  A L Blatz; K L Magleby
Journal:  Nature       Date:  1986 Oct 23-29       Impact factor: 49.962

10.  Nerve stump effects in muscle are independent of synaptic connections and are temporally correlated with nerve degeneration phenomena.

Authors:  O Arancio; M Buffelli; A Cangiano; E Pasino
Journal:  Neurosci Lett       Date:  1992-10-26       Impact factor: 3.046

View more
  5 in total

1.  Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.

Authors:  Ahmad Khedraki; Eric J Reed; Shannon H Romer; Qingbo Wang; William Romine; Mark M Rich; Robert J Talmadge; Andrew A Voss
Journal:  J Neurosci       Date:  2017-07-19       Impact factor: 6.167

Review 2.  Myotonic Dystrophy Type 1 Management and Therapeutics.

Authors:  Cheryl A Smith; Laurie Gutmann
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598

3.  Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.

Authors:  F Rinaldi; A Botta; L Vallo; G Contino; A Morgante; R Iraci; C Catalli; G Silvestri; V M Ventriglia; L Politano; G Novelli
Journal:  Acta Myol       Date:  2008-12

4.  Emerging role of the calcium-activated, small conductance, SK3 K+ channel in distal tubule function: regulation by TRPV4.

Authors:  Jonathan Berrout; Mykola Mamenko; Oleg L Zaika; Lihe Chen; Wenzheng Zhang; Oleh Pochynyuk; Roger G O'Neil
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

5.  Chronic muscle stimulation improves muscle function and reverts the abnormal surface EMG pattern in myotonic dystrophy: a pilot study.

Authors:  Carmelo Chisari; Federica Bertolucci; Stefania Dalise; Bruno Rossi
Journal:  J Neuroeng Rehabil       Date:  2013-08-12       Impact factor: 4.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.